SE9701026D0 - use of avian antibodies - Google Patents

use of avian antibodies

Info

Publication number
SE9701026D0
SE9701026D0 SE9701026A SE9701026A SE9701026D0 SE 9701026 D0 SE9701026 D0 SE 9701026D0 SE 9701026 A SE9701026 A SE 9701026A SE 9701026 A SE9701026 A SE 9701026A SE 9701026 D0 SE9701026 D0 SE 9701026D0
Authority
SE
Sweden
Prior art keywords
avian antibodies
drug
avian
antibodies
pharynx
Prior art date
Application number
SE9701026A
Other languages
English (en)
Swedish (sv)
Inventor
Anders Larsson
Hans Kollberg
Original Assignee
Immun System Ims Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immun System Ims Ab filed Critical Immun System Ims Ab
Priority to SE9701026A priority Critical patent/SE9701026D0/xx
Publication of SE9701026D0 publication Critical patent/SE9701026D0/xx
Priority to SE9701212A priority patent/SE511993C2/sv
Priority to AT98911344T priority patent/ATE267612T1/de
Priority to US09/381,361 priority patent/US6537550B1/en
Priority to ES98911344T priority patent/ES2221705T3/es
Priority to CA2283754A priority patent/CA2283754C/fr
Priority to EP98911344A priority patent/EP0971741B1/fr
Priority to BR9808392-9A priority patent/BR9808392A/pt
Priority to PCT/SE1998/000526 priority patent/WO1998041235A1/fr
Priority to DE69824166T priority patent/DE69824166T2/de
Priority to JP54045198A priority patent/JP4298797B2/ja
Priority to PL98335758A priority patent/PL189128B1/pl
Priority to CN98805027A priority patent/CN1255862A/zh
Priority to AU65312/98A priority patent/AU733107B2/en
Priority to IDW991035A priority patent/ID22942A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9701026A 1997-03-20 1997-03-20 use of avian antibodies SE9701026D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9701026A SE9701026D0 (sv) 1997-03-20 1997-03-20 use of avian antibodies
SE9701212A SE511993C2 (sv) 1997-03-20 1997-04-03 Användning av fågelantikroppar för framställning av läkemedel för behandling av luftvägsinfektioner
AU65312/98A AU733107B2 (en) 1997-03-20 1998-03-20 Use of avian antibodies
EP98911344A EP0971741B1 (fr) 1997-03-20 1998-03-20 Utilisation d'anticorps aviaires
US09/381,361 US6537550B1 (en) 1997-03-20 1998-03-20 Use of avian antibodies
ES98911344T ES2221705T3 (es) 1997-03-20 1998-03-20 Utilizacion de anticuerpos aviares.
CA2283754A CA2283754C (fr) 1997-03-20 1998-03-20 Utilisation d'anticorps aviaires
AT98911344T ATE267612T1 (de) 1997-03-20 1998-03-20 Verwendung von vogel-antikörpern
BR9808392-9A BR9808392A (pt) 1997-03-20 1998-03-20 Uso de anticorpos de aves, e, processo para tratar infecções do trato respiratório.
PCT/SE1998/000526 WO1998041235A1 (fr) 1997-03-20 1998-03-20 Utilisation d'anticorps aviaires
DE69824166T DE69824166T2 (de) 1997-03-20 1998-03-20 Verwendung von vogel-antikörpern
JP54045198A JP4298797B2 (ja) 1997-03-20 1998-03-20 トリの抗体の使用法
PL98335758A PL189128B1 (pl) 1997-03-20 1998-03-20 Zastosowanie przeciwciał ptasich skierowanych przeciwko antygenowi/patogenowi wywołującemu infekcjeukładu oddechowego
CN98805027A CN1255862A (zh) 1997-03-20 1998-03-20 鸟类抗体的应用
IDW991035A ID22942A (id) 1997-03-20 1998-05-20 Penggunaan antibodi burung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701026A SE9701026D0 (sv) 1997-03-20 1997-03-20 use of avian antibodies

Publications (1)

Publication Number Publication Date
SE9701026D0 true SE9701026D0 (sv) 1997-03-20

Family

ID=20406247

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701026A SE9701026D0 (sv) 1997-03-20 1997-03-20 use of avian antibodies

Country Status (14)

Country Link
US (1) US6537550B1 (fr)
EP (1) EP0971741B1 (fr)
JP (1) JP4298797B2 (fr)
CN (1) CN1255862A (fr)
AT (1) ATE267612T1 (fr)
AU (1) AU733107B2 (fr)
BR (1) BR9808392A (fr)
CA (1) CA2283754C (fr)
DE (1) DE69824166T2 (fr)
ES (1) ES2221705T3 (fr)
ID (1) ID22942A (fr)
PL (1) PL189128B1 (fr)
SE (1) SE9701026D0 (fr)
WO (1) WO1998041235A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0300213D0 (sv) * 2003-01-30 2003-01-30 Immun System Uppsala I M S Ab Use of avian antibodies
US20080131442A1 (en) * 2006-06-26 2008-06-05 Science Applications International Corporation IgY antibodies to human telomerase reverse transcriptase
WO2008002285A1 (fr) * 2006-06-26 2008-01-03 Science Applications International Corporation Anticorps igy contre la transcriptase inverse de la télomérase humaine
US20110166328A1 (en) * 2008-09-02 2011-07-07 Huan Nguyen Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
ES2742734T3 (es) 2010-11-23 2020-02-17 Pantheryx Inc Composiciones y procedimientos para el tratamiento en aplicaciones clínicas de espectro general, no diferenciadas o mixtas
CN108992669B (zh) * 2018-08-27 2022-03-22 广州汇高生物科技有限公司 防治呼吸道感染的复合卵黄抗体组合物、雾化吸入溶液剂及制备工艺与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215746A (en) 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
JPS6028937A (ja) * 1983-07-25 1985-02-14 Kitasato Inst:The 非う蝕性抗体および組成物
US5240704A (en) * 1983-07-03 1993-08-31 Kitasato Kenkyusho Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
JPH0641425B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
DE3689717T2 (de) 1985-11-25 1994-10-20 Gen Corp Kk Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
JP2666212B2 (ja) * 1988-03-07 1997-10-22 鐘紡株式会社 抗体およびそれを有効成分とする齲蝕予防剤の製造方法
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
JP3195631B2 (ja) 1991-02-16 2001-08-06 太陽化学株式会社 特異的鶏卵抗体の製造方法
AU666852B2 (en) * 1991-05-01 1996-02-29 Henry M. Jackson Foundation For The Advancement Of Military Medicine A method for treating infectious respiratory diseases
DE4324859A1 (de) * 1992-07-23 1994-01-27 Lion Corp Oral verabreichbare Zusammensetzung zur Behandlung periodontaler Erkrankungen
WO1994015640A1 (fr) * 1993-01-12 1994-07-21 Anthony George Gristina Procedes et compositions pour application directe a forte concentration d'anticorps, produisant une immunite passive
US5681565A (en) * 1993-01-12 1997-10-28 Medical Sciences Research Institute Methods and compositions for passive immunotherapy
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5922344A (en) * 1995-02-10 1999-07-13 Abbott Laboratories Product for prevention of respiratory virus infection and method of use
US5824292A (en) * 1995-04-12 1998-10-20 Quest International B.V. Oral care compositions
JPH0920684A (ja) 1995-07-07 1997-01-21 Lotte Co Ltd チューインガム
JPH0952822A (ja) * 1995-08-10 1997-02-25 Lion Corp 口腔用組成物

Also Published As

Publication number Publication date
EP0971741A1 (fr) 2000-01-19
PL189128B1 (pl) 2005-06-30
CA2283754C (fr) 2011-01-04
ATE267612T1 (de) 2004-06-15
EP0971741B1 (fr) 2004-05-26
JP4298797B2 (ja) 2009-07-22
ES2221705T3 (es) 2005-01-01
CN1255862A (zh) 2000-06-07
AU733107B2 (en) 2001-05-10
AU6531298A (en) 1998-10-12
DE69824166D1 (de) 2004-07-01
WO1998041235A1 (fr) 1998-09-24
ID22942A (id) 1999-12-16
DE69824166T2 (de) 2005-06-23
US6537550B1 (en) 2003-03-25
CA2283754A1 (fr) 1998-09-24
JP2002501487A (ja) 2002-01-15
PL335758A1 (en) 2000-05-22
BR9808392A (pt) 2000-05-23

Similar Documents

Publication Publication Date Title
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
CY1118429T1 (el) Αντισωμα συνδεσης αλφα4βητα7 ιντεγκρινης και η χρηση αυτου εις τη θεραπευτικη αγωγη της φλεγμονωδους νοσου του εντερου
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
NO20010749D0 (no) Forebygging av luftveismucus-produksjon ved administrering av EGF-R antagonister
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
HK1068606A1 (en) Novel aminobenzoephenones
CY1114422T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει αρσενικωδες για τη θεραπευτικη αντιμετωπιση κακοηθειας
SE9701026D0 (sv) use of avian antibodies
DE50000243D1 (de) Verwendung von antikörpern zur vakzinierung gegen krebs
HUP0002170A2 (hu) Egy specifikus 5HT2 receptor antagonista alkalmazása alvás közben fellépő apnoe szindróma kezelésére szolgáló gyógyszerkészítmény előállítására
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
HUP0100080A2 (hu) Mirtazapin alkalmazása alvásiapnoe kezelésére szolgáló gyógyszerkészítmény előállítására
ATE271852T1 (de) Verbesserte inhalationspräparate
ATE201601T1 (de) Pharmazeutische zusammensetzungen enthaltend ein neutralisiertes virus, und verwendung derselben
EA200100515A3 (ru) Диазепиноиндолы для лечения хронического обструктивного заболевания легких
BR9506748A (pt) Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto
SE9902597D0 (sv) New use
ATE498403T1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
HUP0001342A2 (hu) Gyógyszerkészítmény a terméketlenség kezelésére és a termékenység fokozására
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
CA2436537A1 (fr) Nouvelles compositions pharmaceutiques
SE0101258D0 (sv) Treatment of low back pain and whiplash associated disorder
SE9701212D0 (sv) Use of avian antibodies